Yale University
Pediatrics
Stuart A Weinzimer MD, is Professor of Pediatrics at the Yale University School of Medicine, Clinical Professor at the Yale School of Nursing, and Attending Pediatric Endocrinologist at the Yale-New Haven Children’s Hospital. He graduated summa cum laude from Yale University with a bachelor’s degree in Molecular Biochemistry and Biophysics, earned his medical degree at the Albert Einstein College of Medicine, and completed pediatric residency and pediatric endocrinology fellowship training at the Children’s Hospital of Philadelphia. He has spent the last twenty years conducting patient-oriented research focused on the development, evaluation, and implementation of automated insulin delivery systems, the effects of dysglycemia on brain structure and function in children, and behavioral strategies to facilitate technology use and physical activity in youth with diabetes. He has over 250 peer-reviewed publications, reviews and book chapters. When he is not working, he may usually be found close to a piano.

Moderator of 1 Session

Session Type
Parallel Session
Date
Thu, 28.04.2022
Session Time
16:40 - 18:00
Room
Hall 111

Presenter of 1 Presentation

Developing Brain in Children: A Longitudinal DirecNet Study

Session Type
Parallel Session
Date
Thu, 28.04.2022
Session Time
16:40 - 18:00
Room
Hall 111
Lecture Time
17:00 - 17:20

Abstract

Abstract Body

It has been increasingly appreciated that chronic exposure to hyperglycemia is detrimental to the brain, particularly during the critical periods of growth and development in young children. The Diabetes Research in Children Network conducted a longitudinal study focused on neuroanatomical and cognitive consequences of type 1 diabetes (T1D). Over six years of study, we conducted unsedated MRI, cognitive testing batteries, and continuous glucose monitoring assessments in 144 children with diabetes and 72 age-matched controls, beginning at the age of 4-9; compared anatomical and cognitive outcomes between groups; and within the T1D group, correlations with measures of glycemia.

Total brain, gray and white matter volumes, and full-scale and verbal intelligence quotients were lower in the T1D group at all assessment points, and rates of growth of cortical and subcortical gray and white matter were consistently slower in T1D children over this time period spanning childhood and early puberty. Within the T1D group, brain volumes and cognitive scores were negatively correlated with higher CGM-measured glucose levels and a calculated lifetime A1c index. Resting-state fMRI demonstrated increased functional connectivity in executive function control areas in the T1D group, suggesting a mechanism to compensate for the adverse effects of dysglycemia to maintain cognitive and behavioral performance.

The need for improved control of hyperglycemia during the developmental window of childhood and puberty is clear. A recently completed six-month pilot study utilizing automated delivery systems in adolescents with T1D may help to determine the potential impact of improved short-term glycemic control on these critical anatomic and cognitive outcomes.

Hide